ABSTRACT
INTRODUCTION
Connective tissue growth factor (CTGF) is a recently discovered cysteine-rich mitogen produced by endothelial and fibroblast cells [1] [2] [3] . Target cells for CTGF include fibroblasts and smooth muscle cells in which CTGF stimulates induction of mitosis, chemotaxis, and production of extracellular matrix (ECM) macromolecules [1, [4] [5] [6] . CTGF is the product of an immediate early gene that is activated rapidly by transforming growth factor ␤ (TGF␤) [2, [7] [8] [9] and is expressed at high levels at sites of fibroblast hyperplasia, healing dermal wounds, atherosclerotic plaques, and the fibrous stroma of certain mammary tumors [7, [10] [11] [12] [13] . Although the putative signal-transducing membrane receptor for CTGF has yet to be identified, the biological properties of CTGF and its pattern of expression during various pathological states (frequently those in which TGF␤ is implicated) have resulted in speculation that CTGF plays a central role in proliferation of connective tissue cells and production of ECM.
Complementary DNAs have been reported for human, mouse, and porcine CTGF (hCTGF, mCTGF/fisp-12, p-CTGF) [1-3, 5, 14] . After cleavage of their respective signal peptides, the secreted forms of all three proteins are predicted to comprise 323 residues (of which 38 are conserved cysteine residues) and to exhibit Ͼ 95% homology to each other [14] . It has been suggested that the CTGF protein may be organized into four structurally distinct modules and that CTGF is thus a multifunctional mosaic protein [15] . In hCTGF or pCTGF, residues 27-97, 101-167, 199-243, and 256-330 resemble, respectively, an insulin-like growth factor-binding motif (module I), a von Willebrand type C repeat (module II), a glycoconjugatebinding domain (module III), and a dimerization and/or receptor-binding motif that may contain a cysteine knot (module IV) [5, 14, 15] . Forms of CTGF of 36 to 38 kDa have been detected in human endothelial cell-conditioned medium [1] , by in vitro translation of hCTGF RNA [1] , and by radioimmunoprecipitation of metabolically labeled mouse or human fibroblasts or pig endometrial explants using CTGF antisera [3, 6, 14] . While the size of these CTGF proteins is consistent with predictions regarding the size of the primary translational product from cDNA analysis, we have recently shown that pig uterine luminal flushings (ULF) do not contain readily detectable levels of 38-kDa CTGF but instead contain 10-, 16-, and 20-kDa immunoreactive forms of the protein [5] . A detailed analysis of 10-kDa CTGF revealed that it corresponded to two microheterogeneous forms of pCTGF that represented the C-terminal 102 or 103 residues of the primary translational product and thus comprised module IV flanked by 8 or 9 additional residues at its N-terminus plus 19 presumptive residues at its C-terminus [5] . Since the 10-kDa proteins were mitogenic for cultured Balb/c 3T3 cells, these data suggested that modules I-III of CTGF are not essential for CTGF biological activity. Similar low-mass forms of CTGF are present in conditioned medium from cultures of mouse or human fibroblasts [6] .
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In view of the importance of uterine secretory proteins, especially growth factors, in uterine and placental growth [16] [17] [18] [19] [20] , as well as the need to more fully understand CTGF processing, these studies were focused on the characterization of 16-to 20-kDa CTGF in ULF and on identifying a putative mechanism by which low-mass forms of CTGF might be generated in utero.
MATERIALS AND METHODS

Animals
For purification of CTGF, uteri were collected randomly from gilts at a local slaughterhouse. Uterine horns were flushed with 20-50 ml PBS to obtain ULF, which were subsequently clarified by centrifugation at 13 500 ϫ g for 30 min at 4ЊC and passage of the supernatant through glass wool. CTGF levels and CTGF-degrading properties were studied in ULF obtained by flushing each uterine horn of 45 mixed-breed gilts on Days 0-18 of the estrous cycle or pregnancy (Day 0 ϭ 1st day of estrus) with 10 ml PBS.
For Northern blot analysis, uteri were obtained at hysterectomy from pigs on Days 10-16 of the estrous cycle or of pregnancy [21] . Endometrium was dissected from underlying myometrium, immediately frozen in liquid nitrogen, and stored at Ϫ86ЊC. Northern blotting was performed using a 32 P-labeled 596-base pair (bp) pCTGF cDNA (nucleotides 294-889) as previously described [14] .
Purification and Isolation of 16-20-kDa CTGF Proteins from ULF
Heparin-affinity chromatography. CTGF proteins were purified from ULF using successive steps of cation-exchange chromatography, heparin-affinity fast protein liquid chromatography (FPLC), and reverse-phase HPLC that have previously been used for isolation of 10-kDa CTGF [5] . Briefly, Balb/c 3T3 cell mitogens in 2.0-, 1.6-, 1.5-, 2.2-, and 1.8-liter samples of ULF from, respectively, 52, 28, 42, 43, and 37 uteri (202 total) were individually eluted from a BioRex 70 cation-exchange column (Bio-Rad Laboratories, Richmond, CA) by 0.3-0.6 M NaCl in PBS. Fractions from each run were combined into two separate pools of mitogenic material, each of which was subjected to two cycles of heparin-affinity chromatography using an EconoPac heparin column (0.7 ϫ 3.6 cm; Bio-Rad) in the first step and a TSK heparin 5PW column (0.8 ϫ 7.5 cm; TosoHaas, Philadelphia, PA) in the second step [5] . TSK heparin column fractions containing proteins that were eluted by 0.8 M NaCl and that demonstrated mitogenic activity for 3T3 cells were divided into two pools (regions I and II). Each pool (3 ml) was subjected to C 8 reverse-phase HPLC as described previously [5] . In view of the lability of CTGF mitogenic activity under the acidic conditions employed in HPLC [5] , CTGF was subsequently detected in fractions containing the column eluate by Western blotting.
Characterization of CTGF DNA synthesis assays. Fractions from heparin-affinity FPLC of ULF were tested for their ability to stimulate DNA synthesis as measured by [ 3 H]thymidine incorporation into the DNA of confluent quiescent Balb/c 3T3 cells grown for 7 days in 200 l of Dulbecco's Modified Eagle's medium (DMEM)/10% bovine calf serum in 96-well culture plates [5] .
SDS-PAGE and Western blotting. Aliquots (150 l) of selected HPLC fractions were evaporated to dryness in a SpeedVac concentrator (Savant Instruments, Farmingdale, NY) and reconstituted in 35 l 10 mM Tris-HCl (pH 7.4). Twenty microliters of this concentrate was mixed with 20 l of double-strength sample buffer, boiled, and used for analytical SDS-PAGE in which samples were electrophoresed at 20 l/lane under reducing conditions on duplicate 18% polyacrylamide mini gels for approximately 1 h at 200 mA. SDS-PAGE was also performed directly on unfractionated ULF from 45 animals. To permit quantitative comparisons between different animals, the amount of ULF applied to each lane (i.e., 10-35 l) was normalized to 0.1% of the total volume of ULF recovered.
Proteins in the gels were transferred to nitrocellulose membranes in 10 mM 3-[cyclohexylamino]-1-propanesulfonic acid (pH 11.0) for 90 min at 300 V. Blots were blocked for 30 min with 10 mM Tris-HCl/0.15 M NaCl/ 0.25% BSA and incubated overnight with 1:1000 dilution of rabbit preimmune serum or 1:1000 dilution of rabbit anti-pCTGF[247-260] peptide antiserum (rabbit A; see [5] ). Immunoreactive bands were visualized using alkaline phosphatase-conjugated goat anti-rabbit IgG followed by nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate chromogenic substrates. Intensities of individual CTGF bands were calculated using a Storm 860 scanner and ImageQuanNT software (Molecular Dynamics, Sunnyvale, CA). Data were expressed as mean Ϯ SEM pixels per band for each CTGF isoform at each reproductive stage examined.
N-Terminal microsequencing. Fractions containing HPLC-purified immunoreactive CTGF proteins were pooled, dried, and subjected to preparative SDS-PAGE and Western blotting to polvinyldifluoride (PVDF) as described previously [5] . Proteins of interest were located by staining the PVDF with 0.1% Coomassie R250 in 50% methanol for 2 min, excised, and submitted for N-terminal analysis by the BioSciences Sequencing Facility at The Ohio State University, Columbus, OH, and the Molecular Biology Core Laboratory at Case Western Reserve University, Cleveland, OH.
Degradation of 38-kDa CTGF by ULF Radioimmunoprecipitation (RIPA) of 35 S-labeled 38-kDa CTGF. Pig aortic smooth muscle cells were isolated as described previously [5] and used between passages 3 and 5. Cells were grown to approximately 80% confluency in T-75 culture flasks in 15 ml DMEM containing 10% bovine calf serum. They were then transferred to serum-free cysteine/methionine-deficient DMEM for 1 h and labeled for 4 h at 37ЊC with 4-5 ml of the same medium containing 100 Ci/ml [ 35 S]cysteine/methionine (ICN Biomedical, Costa Mesa, CA). Labeling medium was aspirated, and the cell monolayer was lysed in 3 ml cold RIPA buffer (50 mM Tris-HCl [pH 8.0] containing 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, and 0.1% SDS). Cell lysate from two flasks (6 ml) was then precleared by addition of 160 l rabbit B preimmune serum (see below) for 30 min at room temperature followed by shaking with 400 l protein A agarose beads (Pierce Chemical Co., Rockford, IL) for 30 min at 4ЊC. The supernatant was then divided into two aliquots of approximately 2.5 ml, to which was added either 80 l of CTGF[247-260] peptide antiserum or 80 l of preimmune serum (rabbit B; see [5, 6, 14] ). After incubation for 1 h at room temperature, immune complexes were allowed to precipitate for 1 h at 4ЊC by addition of 200 l of protein A beads. Beads were washed four times TC # 316
Heparin-affinity chromatography of ULF. A) Two pools of ULF of 1800 ml and 2200 ml from 37 and 43 animals, respectively, were individually subjected to BioRex cation-exchange chromatography. The 0.3-0.6 M NaCl eluate from each sample was pooled and applied to an EconoPac heparin column, which was then washed with 20 mM Tris-HCl (pH 7.4) containing 0.2 M NaCl/0.1% 3-[(cholamidopropyl)-dimethylammonio]-1-propane-sulfonate (CHAPS). The column was developed with a 40-ml gradient of 0.2-2 M NaCl at 1 ml/min, and fractions of 1 ml were collected. Five-microliter aliquots of each fraction were assayed for their stimulation of DNA synthesis in quiescent Balb/c 3T3 cells. B) Fractions 14-19 from the EconoPac heparin column shown in A were pooled, diluted, and applied to a TSK heparin column, which was washed in 20 mM Tris-HCl/0.2 M NaCl and then developed with a 0.2-2 M NaCl gradient in 20 mM Tris-HCl (pH 7.4). Fractions (0.5 ml) were collected during NaCl gradient elution of the bound proteins and were assayed at 10 l/ ml for their stimulation of 3T3 cell DNA synthesis. The figure shows the individual regions that were selected for HPLC purification.
with 15 ml of RIPA buffer, resuspended in 7.5 ml PBS, and aliquoted into microfuge tubes (0.5 ml/tube). Tubes were centrifuged to pellet the beads, and the supernatant was removed by aspiration.
Incubation of 35 S-labeled 38-kDa CTGF with ULF. CTGF of 38 kDa, complexed on protein A beads, was mixed with either PBS alone or various dilutions (1:8-1: 4096 in PBS) of ULF from a Day 14 nonpregnant gilt for 0, 10, 20, or 180 min at 37ЊC in a final volume of 20 l. The effect of heat treatment on CTGF-degrading activity was determined by boiling a 1:8 dilution of ULF for 1 min prior to its addition to 38-kDa CTGF for 180 min at 37ЊC. All reactions were terminated by addition of 20 l of double-strength SDS-PAGE sample buffer followed by boiling. Aliquots (18 l) were subjected to SDS-PAGE under reducing conditions on 18% polyacrylamide gels, after which the gels were soaked in En 3 Hance (NEN DuPont, Boston, MA), dried, and exposed to x-ray film for 5-8 days.
Degradation of 38-kDa recombinant human CTGF (rhCTGF). Baculovirus-derived 38-kDa rhCTGF was produced and purified essentially as described previously [4] and was kindly provided by Dr. G. Martin and colleagues (FibroGen Inc, South San Francisco, CA). One microgram of rhCTGF was incubated overnight at 37ЊC in a total volume of 10 l PBS containing aliquots of ULF that were all normalized to 0.0007% of the total volume of ULF recovered. Negative control reactions were performed with PBS in the absence of ULF. Since it was not possible to distinguish rhCTGF breakdown products from endogenous lowmass pCTGF proteins in many of the ULF samples, degradation was assessed by the disappearance of the 38-kDa rhCTGF band and was scored semiquantitatively as follows: Ϫ, no breakdown (i.e., same 38-kDa rhCTGF signal as in negative control); ϩ, moderate proteolysis (Յ 50% breakdown of 38-kDa rhCTGF); ϩϩ, high proteolysis (Ͼ 50% breakdown of 38-kDa rhCTGF).
RESULTS
CTGF mitogenic activity was eluted from EconoPac heparin columns by 0.8 M NaCl (Fig. 1A) . When this bioactive region was subjected to chromatography on a TSK heparin column, it was eluted by 0.8 M NaCl and resolved into two regions (regions I and II; Fig. 1B) , each of which stimulated dose-dependent incorporation of [ 3 H]thymidine into Balb/c 3T3 cells (data not shown). In view of the previously reported acid lability of the activity of 10 kDa CTGF [5] , as well as the complete loss of activity of the growth factor activity purified in this study after exposure of the heparin-purified factor(s) to 10% acetonitrile/0.1% trifluoroacetic acid (data not shown), CTGF proteins were detected after reverse-phase HPLC by SDS-PAGE and Western blotting. Analysis of region I after HPLC revealed the presence of 16-kDa CTGF in fractions 21-25, 20-kDa CTGF in fractions 23-25, and 18-kDa CTGF in fractions 25-28 ( Fig. 2A) . Western blotting of HPLC fractions from region II showed the presence of two microheterogeneous 16-kDa CTGF proteins that were successfully separated from one another except in fraction 24, where they formed a 16-kDa doublet (Fig. 2B) .
For structural analysis, peak fractions containing each of the CTGF proteins were dried, subjected to SDS-PAGE, and transferred to PVDF membranes. For each protein, Nterminal sequence data were obtained for up to 16 cycles and showed that relative to the previously described p-CTGF primary translational product [14] , the 16-kDa, 18-kDa, and 20-kDa forms of CTGF from region I commenced at Ala 197 , Asp 186 , and Asp 186 , respectively, and that the two microheterogeneous 16-kDa proteins from region II commenced at Ala 197 and Cys 199 . These data are summarized in Figure 3 , which shows the relationship of the CTGF proteins to each other and to the junction of modules II and III within the pCTGF primary translational product.
Northern blots of endometrial RNA demonstrated a single 2.4-kilobase pCTGF transcript at all stages examined (Days 10, 12, and 14 of the cycle and Days 10, 12, 14, and 16 of pregnancy; data not shown). This transcript was the same size as that previously reported in Day 16 cyclic pig endometrium [14] as well as cultured endothelial cells and fibroblasts of human or mouse origin [1, 3, 6, 7] . These data suggested that the occurrence of 16-to 20-kDa CTGF proteins was not likely a result of alternative splicing of p-CTGF RNA.
To investigate whether 38-kDa CTGF was posttranslationally processed by proteases in ULF, metabolically labeled native 38-kDa pCTGF was immunoprecipitated from 35 S-labeled pig aortic smooth muscle cells and incubated [16] [17] [18] [19] [20] 
. TSK heparin column fractions that contained A) region I or B) region II (see Fig. 1B ) were pooled and individually subjected to C 8 reverse-phase chromatography. After sample application, the column was washed with 10% acetonitrile in water/0.1% trifluoroacetic acid from 0 to 10 min and then developed with 10-90% acetonitrile gradient from 10 to 146 min. The flow rate was 1 ml/min, and 0.5-ml fractions were collected 20 min after the samples were injected. The insets on the left show CTGF Western blots after successive fractions were dried and the equivalent of 43 l of each fraction was loaded into each lane of 18% polyacrylamide gels and subjected to SDS-PAGE and Western blotting using anti-CTGF [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] . None of the immunoreactive proteins were detected by preimmune serum (data not shown). The insets on the right show representative preparative PVDF blots of entire selected fractions that were stained with Coomassie R250 and subjected to N-terminal microsequencing.
FIG. 3. N-terminal amino acid sequences
of CTGF proteins isolated from pig ULF. X indicates no residue identified; * indicates no matching residue.
a From Harding et al. [14] ; b from Ryseck et al. [3] .
with ULF from a Day 14 cycling pig. As shown in Figure  4A , 38-kDa CTGF was stable when incubated for 3 h at 37ЊC in ULF at dilutions greater than 1:256 or in PBS alone. However, there was a dose-dependent decrease in the amount of 38-kDa CTGF after its exposure to ULF dilutions of 1:256-1:8. Moreover, samples exposed to these higher concentrations of ULF contained a ϳ10-kDa protein that was absent from samples treated with lower concentrations of ULF in which 38-kDa CTGF was stable (Fig.   4A ). Processing of 38-kDa CTGF was extremely rapid, with a substantial decrease in its levels within 10 min of exposure to a 1:8 dilution of ULF at 37ЊC (Fig. 4B ). CTGFdegrading activity was destroyed by exposure of ULF to 100ЊC for 1 min (Fig. 4C) . When the same ULF used in these studies was analyzed by Western blotting, endogenous CTGF proteins of 10 and 16-20 kDa were readily detected, whereas 38-kDa CTGF was absent (Fig. 4D) . In contrast to 38-kDa CTGF, the 10-to 20-kDa forms of TC # 316 CTGF were all completely stable in ULF for 2 days at 37ЊC (Fig. 4D) . When aliquots of unpurified ULF were subjected to Western blotting, 10-, 16-, and 20-kDa CTGF were detected by anti-CTGF [247] [248] [249] [250] [251] [252] [253] [254] [255] [256] [257] [258] [259] [260] (Fig. 5) but not by preimmune serum (data not shown), as we have previously demonstrated [5] . Two proteins of 12 kDa and ϳ40 kDa were detected nonspecifically, since they reacted equally with the CTGF antiserum and the preimmune serum (data not shown). The 10-, 16-, and 20-kDa isoforms of CTGF were detected during the estrous cycle at moderate to high levels in 4 of 5 pigs on Day 14, 5 of 5 pigs on Day 16, and 2 of 5 pigs on Day 18 (Fig. 5A) . The highest levels of immunoreactive CTGF were present on Days 16 (n ϭ 3) or 18 (n ϭ 2). CTGF levels were very low or nondetectable on Days 0, 10, or 12 of the cycle (Fig. 5A) . During pregnancy, CTGF signals were weak or absent in 5 of 5 pigs on Day 10 but were then present at moderate to high levels in 5 of 6 pigs on Day 12, 5 of 5 pigs on Day 14, 5 of 5 pigs on Day 16, and 1 of 4 pigs on Day 18 (Fig. 5B) . Overall, ULF from pregnant animals demonstrated the highest level of CTGF on Day 12. Although the three mass forms of CTGF were usually present, ULF from Days 16 and 18 of pregnancy contained predominantly the 10-kDa CTGF protein (Fig.  5B) . These changes were verified by densitometric scanning (Table 1) , which also showed that the intensity of the total CTGF signal in cycling animals was elevated between 4-and 13-fold on Days 14, 16, or 18 as compared to Days 0, 10, or 12. Moreover, the intensity of the total CTGF signal on Day 12 of pregnancy was approximately 7-fold greater than that on Day 10 of pregnancy and about 4-fold greater than that on Day 12 of the cycle (Table 1) . Finally, the same individual ULF samples were incubated at normalized dilutions with 38-kDa rhCTGF, and the level of proteolytic activity for CTGF was determined by Western blotting. CTGF proteolysis did not occur using ULF from cycling animals in 1 of 1 pig on Day 0, 1 of 1 pig on Day 10, 3 of 3 pigs on Day 12, 1 of 5 pigs on Day 14, and 1 of 4 pigs on Day 18 (Fig. 5A ). Moderate to high levels of proteolytic activity for 38-kDa CTGF were present in 4 of 5 pigs on Day 14, 5 of 5 pigs on Day 16, and 3 of 4 pigs on Day 18 of the cycle (Fig. 5A) . In pregnant animals, proteolytic activity for CTGF was absent from 5 of 5 pigs on Day 10 but present at moderate-high levels in 6 of 6 pigs on Day 12 and 4 of 4 pigs on Day 18 and at high levels in 5 of 5 pigs on Day 14 and 5 of 5 pigs on Day 16 (Fig. 5B) . Hence, overall there was a high correlation between the presence and intensity of endogenous 10-to 20-kDa CTGF proteins and proteolytic activity for 38-kDa CTGF.
DISCUSSION
These data demonstrate that, in addition to the previously described 10 000-kDa forms of CTGF [5] , pig ULF contain several intermediate-mass forms of CTGF of 16 000-20 000 kDa. Since 18-kDa and 20-kDa CTGF have a common N-terminus, the 18-kDa protein may be C-terminally truncated or the 20-kDa protein may have additional secondary modifications. Similarly, since the highermass form of 16-kDa CTGF was actually truncated by 2 residues compared to the lower 16-kDa component, the latter may lack certain posttranslational modifications or part of its C-terminus. None of the N-termini of the CTGF proteins identified in this study, or of the previously characterized 10-kDa pCTGF proteins [5] , correspond to the intron-exon boundaries within the CTGF gene [3] ; and only a single 2.4-kilobase transcript appears to be present in uterine tissues (these results and [14] ). Collectively, these data strongly suggest that low-mass CTGF proteins arise posttranslationally rather than through alternative splicing of the CTGF gene. The presence in the same ULF samples of high levels of low-mass CTGFs and potent proteolytic activity for 38-kDa CTGF strongly suggests that limited proteolysis of 38-kDa CTGF is responsible for the observed low-mass forms of CTGF and that it is a normal physiological process in utero.
Of the truncated forms of CTGF so far identified, most have N-termini that commence between modules II and III or between modules III and IV (10-kDa CTGF). An exception is the 16-kDa protein commencing at Cys 199 , the first residue in module III. These data suggest that the modules may be relatively proteaseinsensitive as a result of their folding and intrachain disulfide bridging whereas the intervening cysteine-free regions may be more susceptible to proteolytic cleavage. The presence in ULF of proteases that rapidly degrade 38-kDa CTGF provides a likely explanation for the very low or nondetectable levels of the native 38-kDa protein in ULF (these results and [5] ) despite its synthesis by pig endometrium [14] . Protease mapping of CTGF (not shown) demonstrates predicted trypsin-sensitive sites between Arg 196 and Ala 197 and a chymotrypsin-sensitive site between Leu 245 and Glu 246 that would generate, respectively, one of the two microheterogeneous forms of 16-kDa CTGF identified here and of 10-kDa CTGF identified earlier [5] . However, these and the other low-mass CTGF proteins may arise through cleavage by other as yet undefined mechanisms that may involve several sequential proteolytic steps. While protease activity in ULF appears to be responsible for the production of 10-kDa CTGF from 38-kDa CTGF, the mechanism of production of 16-to 20-kDa CTGF requires further investigation. However, a proteolytic process TC # 316 is the most likely explanation, since there was a high correlation between the levels of 16-to 20-kDa CTGF and proteolytic activity for 38-kDa CTGF in individual ULF samples. It is possible that the experimental conditions used may not have been optimal for production of 16-to 20-kDa CTGF in vitro. For example, important cofactors may have been absent or the proteases responsible for production of 16-to 20-kDa CTGFs may be associated with uterine cell surfaces, unlike those that generate 10-kDa CTGF, which are evidently soluble. In this respect it is of interest that 38-kDa CTGF is frequently cell-associated and appears to bind to heparin-like molecules in the ECM [6, 14, 22] . Alternatively, 38-kDa CTGF may be degraded by intracellular proteases within the endoplasmic reticulum or Golgi apparatus, resulting in direct export of proteolyzed products from the cell. Thus it is possible that 38-kDa CTGF is proteolytically processed by cell-associated or secreted enzymes that result in its liberation from intracellular or extracellular locations and appearance in ULF as soluble, stable, bioactive low-mass forms.
It is well recognized that uterine fluids of several mammalian species, including the pig, contain a variety of protease activities. ULF from ovariectomized gilts contains leucine aminopeptidase, lysozyme, and cathepsin B1, D, and E, which are estrogen-and/or progesterone-dependent [23, 24] . Pig ULF also contains plasminogen activator and its substrate plasminogen [25] , thus providing the potential for production of plasmin, a broadly specific protease. In addition, several protease inhibitors have been identified in pig ULF, including a 14-kDa Kunitz-type plasmin/trypsin inhibitor [26, 27] and antileukoproteinase [28] . These inhibitors may control the protease activities of the conceptus, especially in species such as the pig that exhibit noninvasive placentation [26] . However, an alternative role may be to protect components of uterine secretory fluids from proteolytic degradation [26] , highlighting the possibility that the level of each CTGF protein in ULF likely reflects a highly controlled balance between CTGF proteases and protease inhibitors.
Studies of CTGF isoforms and CTGF protease activity during the cycle and pregnancy revealed a number of interesting features. First, the presence of low-mass forms of CTGF was correlated with the presence of proteolytic activity for 38-kDa CTGF, suggesting a likely causative relationship and possibly coexpression of their respective genes. Secondly, CTGF protein levels in pregnant animals were higher on Day 12 of pregnancy than on Day 12 of the cycle. A similar result was obtained in a previous study showing that CTGF bioactivity in ULF (assessed by comparison of heparin-purified mitogenic activity) was higher on Day 11.5 of pregnancy as compared to the cycle [29] . Although the underlying mechanism requires further studies, it is possible that blastocyst estrogens, which peak around Days 11-12 [30] , are involved in enhanced production, secretion, and/or solubilization of CTGF. Alternatively, the pig blastocyst, which undergoes rapid morphological changes at this time [31] , may produce CTGF itself or alternatively may induce uterine CTGF through its production of TGF␤, which occurs as early as Day 10 [32] . TGF␤ is a potent and rapid inducer of CTGF gene expression [2, [7] [8] [9] and has been implicated as an initiator of CTGF production in growth factor cascades during processes such as wound healing [7] , fibroplasia [4] , and fibrotic diseases [10, 11] . Thirdly, the peak levels of CTGF in ULF on Day 16 of the cycle contrast with the diminishing levels at the same stage of pregnancy. Again, while the underlying mechanisms remain unclear, the decrease in uterine luminal CTGF may reflect its utilization by uterine or conceptus tissues during this period, possibly for tissue remodeling and growth during the attachment and placentation phases. Several biological properties of CTGF are consistent with its potential role in these processes, including its ability to stimulate cell growth, chemotaxis, cell adhesion, and synthesis of ECM components such as type I collagen, fibronectin, and ␣5 integrin [1, [4] [5] [6] 22] , as well as potentiation of the activity of basic fibroblast growth factor [22] , which is produced by pig uterine and conceptus tissues on Days 10-14 [33] .
It is well recognized that the molecular mechanisms regulating uterine protein secretion are complex and that they involve steroid hormonal control (both embryonic and maternal) of gene transcription and translation as well as of the timing and localization of protein export and processing [20] . Although in the case of CTGF, many of these parameters require further study, our data suggest that CTGF may play a potentially important role in regulating cell function in the uterine tract in both pregnant and nonpregnant pigs. Moreover, the identification in uterine secretions of potent proteolytic activity for 38-kDa CTGF and multiple lowmass forms of CTGF suggests that limited posttranslational proteolytic processing of CTGF is an important component of its mode of action in utero.
